170 related articles for article (PubMed ID: 9688067)
1. Improving stability and release kinetics of microencapsulated tetanus toxoid by co-encapsulation of additives.
Johansen P; Men Y; Audran R; Corradin G; Merkle HP; Gander B
Pharm Res; 1998 Jul; 15(7):1103-10. PubMed ID: 9688067
[TBL] [Abstract][Full Text] [Related]
2. Release of tetanus toxoid from adjuvants and PLGA microspheres: how experimental set-up and surface adsorption fool the pattern.
Johansen P; Corradin G; Merkle HP; Gander B
J Control Release; 1998 Dec; 56(1-3):209-17. PubMed ID: 9801444
[TBL] [Abstract][Full Text] [Related]
3. Diphtheria and tetanus toxoid microencapsulation into conventional and end-group alkylated PLA/PLGAs.
Johansen P; Tamber H; Merkle HP; Gander B
Eur J Pharm Biopharm; 1999 May; 47(3):193-201. PubMed ID: 10382103
[TBL] [Abstract][Full Text] [Related]
4. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D,L-lactic-co-glycolic acid) versus chitosan microspheres.
Jaganathan KS; Rao YU; Singh P; Prabakaran D; Gupta S; Jain A; Vyas SP
Int J Pharm; 2005 Apr; 294(1-2):23-32. PubMed ID: 15814228
[TBL] [Abstract][Full Text] [Related]
5. Enhanced immunogenicity of microencapsulated tetanus toxoid with stabilizing agents.
Audran R; Men Y; Johansen P; Gander B; Corradin G
Pharm Res; 1998 Jul; 15(7):1111-6. PubMed ID: 9688068
[TBL] [Abstract][Full Text] [Related]
6. Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.
Alonso MJ; Gupta RK; Min C; Siber GR; Langer R
Vaccine; 1994 Mar; 12(4):299-306. PubMed ID: 8178550
[TBL] [Abstract][Full Text] [Related]
7. Improved immunogenicity of a core-coated tetanus toxoid delivery system.
Tobío M; Schwendeman SP; Guo Y; McIver J; Langer R; Alonso MJ
Vaccine; 1999 Nov; 18(7-8):618-22. PubMed ID: 10547420
[TBL] [Abstract][Full Text] [Related]
8. Chronic local tissue reactions, long-term immunogenicity and immunologic priming of mice and guinea pigs to tetanus toxoid encapsulated in biodegradable polymer microspheres composed of poly lactide-co-glycolide polymers.
Gupta RK; Alroy J; Alonso MJ; Langer R; Siber GR
Vaccine; 1997 Nov; 15(16):1716-23. PubMed ID: 9364673
[TBL] [Abstract][Full Text] [Related]
9. Formulation strategies for the stabilization of tetanus toxoid in poly(lactide-co-glycolide) microspheres.
Sánchez A; Villamayor B; Guo Y; McIver J; Alonso MJ
Int J Pharm; 1999 Aug; 185(2):255-66. PubMed ID: 10460920
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin loaded microspheres prepared from biodegradable LPLG-PEO-LPLG triblock copolymers: protein stabilization and in-vitro release properties.
Morlock M; Kissel T; Li YX; Koll H; Winter G
J Control Release; 1998 Dec; 56(1-3):105-15. PubMed ID: 9801434
[TBL] [Abstract][Full Text] [Related]
11. Determinants of release rate of tetanus vaccine from polyester microspheres.
Alonso MJ; Cohen S; Park TG; Gupta RK; Siber GR; Langer R
Pharm Res; 1993 Jul; 10(7):945-53. PubMed ID: 8378256
[TBL] [Abstract][Full Text] [Related]
12. Comparison of in vitro and in vivo methods to study stability of PLGA microencapsulated tetanus toxoid vaccines.
Sasiak AB; Bolgiano B; Crane DT; Hockley DJ; Corbel MJ; Sesardic D
Vaccine; 2000 Nov; 19(7-8):694-705. PubMed ID: 11115690
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of single-dose diphtheria vaccines based on PLA/PLGA microspheres in guinea pigs.
Johansen P; Moon L; Tamber H; Merkle HP; Gander B; Sesardic D
Vaccine; 1999 Sep; 18(3-4):209-15. PubMed ID: 10506644
[TBL] [Abstract][Full Text] [Related]
14. Tetanus toxoid microspheres consisting of biodegradable poly(lactide-co-glycolide)- and ABA-triblock-copolymers: immune response in mice.
Jung T; Koneberg R; Hungerer KD; Kissel T
Int J Pharm; 2002 Mar; 234(1-2):75-90. PubMed ID: 11839439
[TBL] [Abstract][Full Text] [Related]
15. A novel system based on a poloxamer/PLGA blend as a tetanus toxoid delivery vehicle.
Tobío M; Nolley J; Guo Y; McIver J; Alonso MJ
Pharm Res; 1999 May; 16(5):682-8. PubMed ID: 10350011
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of tetanus toxoid encapsulated in PLGA microspheres.
Jiang W; Schwendeman SP
Mol Pharm; 2008; 5(5):808-17. PubMed ID: 18710256
[TBL] [Abstract][Full Text] [Related]
17. Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres.
Johansen P; Estevez F; Zurbriggen R; Merkle HP; Glück R; Corradin G; Gander B
Vaccine; 2000 Dec; 19(9-10):1047-54. PubMed ID: 11137238
[TBL] [Abstract][Full Text] [Related]
18. Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice.
Jung T; Kamm W; Breitenbach A; Hungerer KD; Hundt E; Kissel T
Pharm Res; 2001 Mar; 18(3):352-60. PubMed ID: 11442276
[TBL] [Abstract][Full Text] [Related]
19. Biodegradable PLGA microspheres loaded with ganciclovir for intraocular administration. Encapsulation technique, in vitro release profiles, and sterilization process.
Herrero-Vanrell R; Ramirez L; Fernandez-Carballido A; Refojo MF
Pharm Res; 2000 Oct; 17(10):1323-8. PubMed ID: 11145241
[TBL] [Abstract][Full Text] [Related]
20. Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen.
Chang AC; Gupta RK
J Pharm Sci; 1996 Feb; 85(2):129-32. PubMed ID: 8683435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
